BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28053239)

  • 21. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
    Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
    J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of connective tissue growth factor expression by miR-133b for the treatment of renal interstitial fibrosis in aged mice with unilateral ureteral obstruction.
    Cao D; Wang Y; Zhang Y; Zhang Y; Huang Q; Yin Z; Cai G; Chen X; Sun X
    Stem Cell Res Ther; 2021 Mar; 12(1):171. PubMed ID: 33691785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and role of SCAI during renal fibrosis and epithelial-to-mesenchymal transition.
    Fintha A; Gasparics Á; Fang L; Erdei Z; Hamar P; Mózes MM; Kökény G; Rosivall L; Sebe A
    Am J Pathol; 2013 Feb; 182(2):388-400. PubMed ID: 23178076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.
    Wang X; Gao Y; Tian N; Zou D; Shi Y; Zhang N
    Drug Des Devel Ther; 2018; 12():2431-2442. PubMed ID: 30122901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells.
    Loeffler I; Hopfer U; Koczan D; Wolf G
    J Am Soc Nephrol; 2011 Apr; 22(4):649-63. PubMed ID: 21372207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis.
    Xu J; Xiang P; Liu L; Sun J; Ye S
    J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
    Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
    Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
    Wang T; Chen SS; Chen R; Yu DM; Yu P
    Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway.
    Lan T; Liu W; Xie X; Huang K; Peng J; Huang J; Shen X; Liu P; Yang H; Huang H
    Eur J Pharmacol; 2012 Dec; 697(1-3):165-72. PubMed ID: 23085271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
    PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.
    Bera A; Das F; Ghosh-Choudhury N; Mariappan MM; Kasinath BS; Ghosh Choudhury G
    Am J Physiol Cell Physiol; 2017 Oct; 313(4):C430-C447. PubMed ID: 28701356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silenced miR-21 inhibits renal interstitial fibrosis via targeting ERK1/2 signaling pathway in mice.
    Tang CR; Luo SG; Lin X; Wang J; Liu Y
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):110-116. PubMed ID: 31389582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1.
    Ma J; Zhang L; Hao J; Li N; Tang J; Hao L
    J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-133 modulates TGF-β1-induced bladder smooth muscle cell hypertrophic and fibrotic response: implication for a role of microRNA in bladder wall remodeling caused by bladder outlet obstruction.
    Duan LJ; Qi J; Kong XJ; Huang T; Qian XQ; Xu D; Liang JH; Kang J
    Cell Signal; 2015 Feb; 27(2):215-27. PubMed ID: 25451078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells.
    Wang D; Guan MP; Zheng ZJ; Li WQ; Lyv FP; Pang RY; Xue YM
    Cell Physiol Biochem; 2015; 36(6):2093-107. PubMed ID: 26279418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y; Lin C; Ren Q; Liu Y; Yang X
    Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice.
    Kölling M; Kaucsar T; Schauerte C; Hübner A; Dettling A; Park JK; Busch M; Wulff X; Meier M; Scherf K; Bukosza N; Szénási G; Godó M; Sharma A; Heuser M; Hamar P; Bang C; Haller H; Thum T; Lorenzen JM
    Mol Ther; 2017 Jan; 25(1):165-180. PubMed ID: 28129112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.